- Home
- LNTH vs NYT Comparison
LNTH vs NYT Comparison
Compare LNTH & NYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- NYT
- Stock Information
- Founded
- LNTH 1956
- NYT 1851
- Country
- LNTH United States
- NYT United States
- Employees
- LNTH N/A
- NYT N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NYT Newspapers/Magazines
- Sector
- LNTH Health Care
- NYT Consumer Discretionary
- Exchange
- LNTH Nasdaq
- NYT Nasdaq
- Market Cap
- LNTH 7.5B
- NYT 8.6B
- IPO Year
- LNTH 2015
- NYT N/A
- Fundamental
- Price
- LNTH $81.74
- NYT $53.63
- Analyst Decision
- LNTH Strong Buy
- NYT Buy
- Analyst Count
- LNTH 5
- NYT 6
- Target Price
- LNTH $133.80
- NYT $55.50
- AVG Volume (30 Days)
- LNTH 1.2M
- NYT 1.7M
- Earning Date
- LNTH 05-07-2025
- NYT 05-07-2025
- Dividend Yield
- LNTH N/A
- NYT 1.34%
- EPS Growth
- LNTH N/A
- NYT 21.26
- EPS
- LNTH 3.53
- NYT 1.83
- Revenue
- LNTH $1,536,699,000.00
- NYT $2,600,814,000.00
- Revenue This Year
- LNTH $5.81
- NYT $8.41
- Revenue Next Year
- LNTH $12.26
- NYT $5.95
- P/E Ratio
- LNTH $23.18
- NYT $29.38
- Revenue Growth
- LNTH 12.53
- NYT 6.90
- 52 Week Low
- LNTH $74.34
- NYT $44.83
- 52 Week High
- LNTH $126.89
- NYT $58.16
- Technical
- Relative Strength Index (RSI)
- LNTH 29.92
- NYT 73.50
- Support Level
- LNTH $78.92
- NYT $51.31
- Resistance Level
- LNTH $108.91
- NYT $53.35
- Average True Range (ATR)
- LNTH 3.82
- NYT 1.04
- MACD
- LNTH -2.81
- NYT 0.23
- Stochastic Oscillator
- LNTH 9.40
- NYT 96.13
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About NYT New York Times Company (The)
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.